Human Immunodeficiency Virus/AIDS, Human Papillomavirus, and Anal Cancer

Chia ching J Wang, Joseph A. Sparano, Joel M. Palefsky

Research output: Contribution to journalReview article

13 Citations (Scopus)

Abstract

Anal cancer is an increasingly common non–AIDS-defining cancer among individuals infected with the human immunodeficiency virus (HIV). It is associated with human papillomavirus (HPV). HPV16 is the most common genotype detected in anal cancers. The HPV types detected in anal cancer are included in the 9-valent vaccine. HPV vaccines have demonstrated efficacy in reducing anal precancerous lesions in HIV-infected individuals. Standard treatment has been fluorouracil and mitomycin (or cisplatin) plus radiation. Continued studies are needed to test new treatment strategies in HIV-infected patients with anal cancer to determine which treatment protocols provide the best therapeutic index.

Original languageEnglish (US)
Pages (from-to)17-31
Number of pages15
JournalSurgical Oncology Clinics of North America
Volume26
Issue number1
DOIs
StatePublished - Jan 1 2017

Fingerprint

Anus Neoplasms
Acquired Immunodeficiency Syndrome
HIV
Papillomavirus Vaccines
Mitomycin
Clinical Protocols
Fluorouracil
Cisplatin
Therapeutics
Vaccines
Genotype
Radiation
Neoplasms

Keywords

  • Anal cancer
  • HIV
  • HPV
  • HPV vaccination
  • Immunosuppression

ASJC Scopus subject areas

  • Surgery
  • Oncology

Cite this

Human Immunodeficiency Virus/AIDS, Human Papillomavirus, and Anal Cancer. / Wang, Chia ching J; Sparano, Joseph A.; Palefsky, Joel M.

In: Surgical Oncology Clinics of North America, Vol. 26, No. 1, 01.01.2017, p. 17-31.

Research output: Contribution to journalReview article

@article{a01263e1242d410cae25062e78214a08,
title = "Human Immunodeficiency Virus/AIDS, Human Papillomavirus, and Anal Cancer",
abstract = "Anal cancer is an increasingly common non–AIDS-defining cancer among individuals infected with the human immunodeficiency virus (HIV). It is associated with human papillomavirus (HPV). HPV16 is the most common genotype detected in anal cancers. The HPV types detected in anal cancer are included in the 9-valent vaccine. HPV vaccines have demonstrated efficacy in reducing anal precancerous lesions in HIV-infected individuals. Standard treatment has been fluorouracil and mitomycin (or cisplatin) plus radiation. Continued studies are needed to test new treatment strategies in HIV-infected patients with anal cancer to determine which treatment protocols provide the best therapeutic index.",
keywords = "Anal cancer, HIV, HPV, HPV vaccination, Immunosuppression",
author = "Wang, {Chia ching J} and Sparano, {Joseph A.} and Palefsky, {Joel M.}",
year = "2017",
month = "1",
day = "1",
doi = "10.1016/j.soc.2016.07.010",
language = "English (US)",
volume = "26",
pages = "17--31",
journal = "Surgical Oncology Clinics of North America",
issn = "1055-3207",
publisher = "W.B. Saunders Ltd",
number = "1",

}

TY - JOUR

T1 - Human Immunodeficiency Virus/AIDS, Human Papillomavirus, and Anal Cancer

AU - Wang, Chia ching J

AU - Sparano, Joseph A.

AU - Palefsky, Joel M.

PY - 2017/1/1

Y1 - 2017/1/1

N2 - Anal cancer is an increasingly common non–AIDS-defining cancer among individuals infected with the human immunodeficiency virus (HIV). It is associated with human papillomavirus (HPV). HPV16 is the most common genotype detected in anal cancers. The HPV types detected in anal cancer are included in the 9-valent vaccine. HPV vaccines have demonstrated efficacy in reducing anal precancerous lesions in HIV-infected individuals. Standard treatment has been fluorouracil and mitomycin (or cisplatin) plus radiation. Continued studies are needed to test new treatment strategies in HIV-infected patients with anal cancer to determine which treatment protocols provide the best therapeutic index.

AB - Anal cancer is an increasingly common non–AIDS-defining cancer among individuals infected with the human immunodeficiency virus (HIV). It is associated with human papillomavirus (HPV). HPV16 is the most common genotype detected in anal cancers. The HPV types detected in anal cancer are included in the 9-valent vaccine. HPV vaccines have demonstrated efficacy in reducing anal precancerous lesions in HIV-infected individuals. Standard treatment has been fluorouracil and mitomycin (or cisplatin) plus radiation. Continued studies are needed to test new treatment strategies in HIV-infected patients with anal cancer to determine which treatment protocols provide the best therapeutic index.

KW - Anal cancer

KW - HIV

KW - HPV

KW - HPV vaccination

KW - Immunosuppression

UR - http://www.scopus.com/inward/record.url?scp=85006288696&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85006288696&partnerID=8YFLogxK

U2 - 10.1016/j.soc.2016.07.010

DO - 10.1016/j.soc.2016.07.010

M3 - Review article

C2 - 27889034

AN - SCOPUS:85006288696

VL - 26

SP - 17

EP - 31

JO - Surgical Oncology Clinics of North America

JF - Surgical Oncology Clinics of North America

SN - 1055-3207

IS - 1

ER -